160 related articles for article (PubMed ID: 22918868)
21. [In vitro activity of caspofungin against fluconazole-resistant Candida isolates from patients with HIV infection].
Ortiz de la Tabla-Ducasse V; Masiá-Canuto M; Martín-González C; Gutiérrez-Rodero F
Enferm Infecc Microbiol Clin; 2004; 22(6):328-31. PubMed ID: 15228899
[TBL] [Abstract][Full Text] [Related]
22. In vitro antifungal susceptibility testing of Candida blood isolates and evaluation of the E-test method.
Lu JJ; Lee SY; Chiueh TS
J Microbiol Immunol Infect; 2004 Dec; 37(6):335-42. PubMed ID: 15599465
[TBL] [Abstract][Full Text] [Related]
23. Brief exposure to antimycotics reduces the extracellular phospholipase activity of Candida albicans and Candida tropicalis.
Anil S; Samaranayake LP
Chemotherapy; 2003 Sep; 49(5):243-7. PubMed ID: 14504435
[TBL] [Abstract][Full Text] [Related]
24. Mode of action and anti-Candida activity of Artemisia annua mediated-synthesized silver nanoparticles.
Khatoon N; Sharma Y; Sardar M; Manzoor N
J Mycol Med; 2019 Sep; 29(3):201-209. PubMed ID: 31378442
[TBL] [Abstract][Full Text] [Related]
25. iTRAQ-based proteomics revealed baicalein enhanced oxidative stress of Candida albicans by upregulating CPD2 expression.
Lv QZ; Zhang XL; Gao L; Yan L; Jiang YY
Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36055797
[TBL] [Abstract][Full Text] [Related]
26. In vitro susceptibility of Candida spp. to fluconazole, itraconazole and voriconazole and the correlation between triazoles susceptibility: Results from a five-year study.
Lei J; Xu J; Wang T
J Mycol Med; 2018 Jun; 28(2):310-313. PubMed ID: 29685520
[TBL] [Abstract][Full Text] [Related]
27. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
Cocuaud C; Rodier MH; Daniault G; Imbert C
J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
[TBL] [Abstract][Full Text] [Related]
28. Combination effects of baicalein with antibiotics against oral pathogens.
Jang EJ; Cha SM; Choi SM; Cha JD
Arch Oral Biol; 2014 Nov; 59(11):1233-41. PubMed ID: 25129811
[TBL] [Abstract][Full Text] [Related]
29. Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis.
Ishida K; Fernandes Rodrigues JC; Cammerer S; Urbina JA; Gilbert I; de Souza W; Rozental S
Ann Clin Microbiol Antimicrob; 2011 Jan; 10():3. PubMed ID: 21255433
[TBL] [Abstract][Full Text] [Related]
30. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV
Shokri H; Sharifzadeh A
J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362
[TBL] [Abstract][Full Text] [Related]
31. Interactions between Terpinen-4-ol and Nystatin on biofilm of Candida albicans and Candida tropicalis.
Tonon CC; Francisconi RS; Bordini EAF; Huacho PMM; Sardi JCO; Spolidorio DMP
Braz Dent J; 2018; 29(4):359-367. PubMed ID: 30462762
[TBL] [Abstract][Full Text] [Related]
32. Antifungal activity of spider venom-derived peptide lycosin-I against Candida tropicalis.
Tan L; Bai L; Wang L; He L; Li G; Du W; Shen T; Xiang Z; Wu J; Liu Z; Hu M
Microbiol Res; 2018 Nov; 216():120-128. PubMed ID: 30269852
[TBL] [Abstract][Full Text] [Related]
33. [In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms].
Valentín A; Cantón E; Pemán J; Quindós G
Rev Iberoam Micol; 2007 Dec; 24(4):272-7. PubMed ID: 18095759
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the "Dip Effect" Phenomenon in Antifungal Susceptibility Testing of Candida spp. against Echinocandins by Use of Gradient Concentration Strips.
Siopi M; Tsala M; Siafakas N; Zerva L; Meletiadis J
J Clin Microbiol; 2015 Nov; 53(11):3654-9. PubMed ID: 26338855
[TBL] [Abstract][Full Text] [Related]
35. In vitro synergy of baicalein and gentamicin against vancomycin-resistant Enterococcus.
Chang PC; Li HY; Tang HJ; Liu JW; Wang JJ; Chuang YC
J Microbiol Immunol Infect; 2007 Feb; 40(1):56-61. PubMed ID: 17332908
[TBL] [Abstract][Full Text] [Related]
36. In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
Swinne D; Watelle M; Nolard N
Rev Iberoam Micol; 2005 Mar; 22(1):24-8. PubMed ID: 15813679
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of fluconazole on Candida albicans.
Abecia LC; Arévalo JM; López MJ
Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of biofilm- and hyphal- development, two virulent features of Candida albicans by secondary metabolites of an endophytic fungus Alternaria tenuissima having broad spectrum antifungal potential.
Chatterjee S; Ghosh R; Mandal NC
Microbiol Res; 2020 Feb; 232():126386. PubMed ID: 31816593
[TBL] [Abstract][Full Text] [Related]
39. Influence of different susceptibility testing methods and media on determination of the relevant fluconazole minimum inhibitory concentrations for heavy trailing Candida isolates with low-high phenotype.
Alp S; Sancak B; Hascelik G; Arikan S
Mycoses; 2010 Nov; 53(6):475-80. PubMed ID: 19563491
[TBL] [Abstract][Full Text] [Related]
40. In vitro effectiveness of anidulafungin against Candida sp. biofilms.
Rosato A; Piarulli M; Schiavone BP; Catalano A; Carocci A; Carrieri A; Carone A; Caggiano G; Franchini C; Corbo F; Montagna MT
J Antibiot (Tokyo); 2013 Dec; 66(12):701-4. PubMed ID: 24022607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
